IL13RA2 and prostate carcinoma: To determine whether the expression of the IL-13Rα2 gene is altered in prostate cancer, we assessed IL-13Rα2 expression at the mRNA level in human prostate cancer tissues using the TissueScan prostate cancer cDNA array via RT-PCR.